FEATURES OF THALAMIC NEURODEGENERATION IN PATIENTS WITH MULTIPLE SCLEROSIS

Currently the role of CNS structures atrophy in disability development in patients with multiple sclerosis (MS) is undisputed. Particular attention is paid to the atrophy of the thalamus, which is associated with a lot of passing through pathways and determine its sensitivity to changes in various parts of the central nervous system. The causes and sequence of the neurodegenerative processes development in MS are still the subject of scientific debates. The aim of our study was to determine the characteristics of neurodegenerative changes in the thalamus in cohort of MS patients with different severity of disability. The study involved 117 patients with clinically isolated syndrome of probable demyelination and multiple sclerosis, according to McDonald criteria (2010) at the age of 18 to 64 and disease duration varied from 1 to 30 years (6,57+7,18). Examination program included a clinical test and MRI, as well as single-voxel proton magnetic resonance spectroscopy (¹H-MRS), performed in 34 patients and 5 healthy volunteers. The results of our study showed that the thalamus atrophy plays an important role in development of disability in patients with multiple sclerosis. It is also reached significance in patients with a more than three points of disability score according to EDSS scale. In carrying out the correlation and analysis of variance data¹H-MRS statistically significant results were obtained only for the correlation analysis of NAA concentration and severity of disability in the left thalamus, which showed a direct correlation. NAA levels in the right thalamus depending on the severity of the disease were not significantly changed. Comparison of the results of morphometric analysis and¹H-MRS data leaded to conclusion that a decrease of the thalamus volume is mainly due to structural damage of the pathways, with relative preservation of gray matter. The findings may contribute to the formation of therapeutic approaches aimed at preventing the development of disability in patients with MS.

таламус, нейродегенерация, рассеянный склероз, МР-спектроскопия, thalamus, neurodegeneration, multiple sclerosis, MR-spectroscopy

1. Houtchens M. K., Benedict R. H., Killiany R. et al. Thalamic atrophy and cognition in multiple sclerosis // Neurology.- 2007.- Vol. 69.- P. 1213-1223.

2. Henry R. G., Shieh M., Okuda D. T. et al. Regional grey matter atrophy in clinically isolated syndromes at presentation // J. Neurol Neurosurg Psychiatry.- 2008.- Vol. 79.- P 1236-1244.

3. Bermel R. A., Sharma J., Tjoa C. W. et al. A semiautomated measure of whole-brain atrophy in multiple sclerosis // J. of the Neurological Sciences.- 2003b.- Vol. 208.- P 57-65.

4. Прахова Л. Н., Ильвес А. Г., Катаева Г. В. и др. Роль атрофии и метаболических изменений в головном мозге в формировании двигательных нарушений у пациентов с рассеянным склерозом // Лучевая диагностика и терапия.- 2010.- Т. 1, № 1.- С. 27-35.

5. Ramasamy D. P., Benedict R. H., Cox J. L. et al. Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study // J. Neurol Sci.- 2009.- Vol. 282.- P 47-54.

6. Rocca M. A., Mesaros S., Pagani E. et al. Thalamic damage and long-term progression of disability in multiple sclerosis // Radiology. - 2010a.- Vol. 257.- P 463-469.

7. Audoin B., Zaaraoui W., Reuter F. et al. Atrophy mainly affects the limbic system and the deep grey matter at the first stage of multiple sclerosis // Neurol Neurosurg Psychiatry.- 2010.- Vol. 81.- P. 690-695.

8. Raz E., Cercignani M., Sbardella E. et al. Clinically Isolated Syndrome Suggestive of Multiple Sclerosis: Voxelwise Regional Investigation of White and Gray Matter // Radiology.- 2010.- Vol. 254.- P 227-234.

9. Calabrese M., Rinaldi F., Grossi P., Gallo P. Cortical pathology and cognitive impairment in multiple sclerosis // Expert Rev Neurother.- 2011a.- Vol. 11.- P 425-432.

10. Wylezinska M., Cifelli A., Jezzard P. et al. Thalamic neurodegeneration in relapsing-remitting multiple sclerosis // Neurology.- 2003.- Vol. 60 (12).- P 1949-1954.

11. Taylor I., Butzkueven H., Litewka L. et al. Serial MRI in multiple sclerosis: a prospective pilot study of lesion load, whole brain volume and thalamic atrophy // Journal of Clinical Neuroscience.- 2004.- Vol. 11.- P 153-158.

12. Narayana P. A. Magnetic resonance spectroscopy in the monitoring of multiple sclerosis // J Neuroimaging.- 2005.- Vol. 15 (4 Suppl).- P 46S-57S.

13. Bitsch A., Bruhn H., Vougioukas V et al. Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy // Am. J. Neuroradiol.- 1999.- Vol. 20 (9).- P 1619-1627.

14. Поздняков А. В. Роль протонной магнитно-резонансной спектроскопии в диагностике заболеваний головного мозга: автореф. дис.. д-ра мед. наук: 14.00.19 / Поздняков Александр Владимирович.- СПб., 2001.- 32 с.

15. Signoretti S., Marmarou A., Tavazzi B. et al. N-acetylaspartate reduction as a measure of injury severity and mitochondrial dysfunction following diffuse traumatic brain injury // J. Neurotrauma.- 2001.- Vol. 18.- P 977-991.

16. Ariyannur P S., Madhavarao C. N., Namboodiri A. M. N-acetylaspartate synthesis in the brain: mitochondria versus microsomes // Brain Res.- 2008.- Vol. 1227.- P 34-41.

17. Cifelli A., Arridge M., Jezzard P Thalamic neurodegeneration in multiple sclerosis // Annals of Neurology.- 2002.- Vol. 52.- P. 650-653.

18. Wylezinska M., Cifelli A., Jezzard P. et al. Thalamic neurodegeneration in relapsing-remitting multiple sclerosis // Neurology.- 2003.- Vol. 60 (12).- P 1949-1954.

19. Geurts J., Reuling I., Vrenken H. et al. MR Spectroscopic Evidence for Thalamic and Hippocampal, but Not Cortical, Damage in Multiple Sclerosis Magnetic Resonance in Medicine // Magn. Reson. Med.- 2006.- Vol. 55 (3).- P 478-483.

20. Inglese M., Liu S., Babb J.S. et al. Threedimensional proton spectroscopy of deep gray matter nuclei in relapsing-remitting MS // Neurology.- 2004.- Vol. 63.- P 170-172.

21. McDonald W., Compston A., Edan G. et al. Recommended Diagnostic Criteria for Multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis // Ann. Neurol.- 2001.- Vol. 50, N 1.- P 121-127.

22. Polman C. H., Reingold S. C., Edan G. et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the «McDonald Criteria»/ // Ann Neurol.- 2005.- Vol. 58 (6).- P 840-846.

23. Polman C. H., Reingold S. C., Banwell B. et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria // Ann Neurol.- 2011.- Vol. 69 (2).- P 292-302.

24. Kurtzke J. F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) // Neurology.- 1983.- Vol. 33, № 12.- P 1444-1452.

25. Shiee N., Bazin P.-L., Zackowski K. M. et al. Revisiting Brain Atrophy and Its Relationship to Disability in Multiple Sclerosis [Электронный ресурс] // PLoS One.- 2012.- Vol. 5 (7).- e37049. doi: 10.1371/journal.pone.0037049.